Janet Clarke

1.1k total citations
15 papers, 631 citations indexed

About

Janet Clarke is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Janet Clarke has authored 15 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Janet Clarke's work include Reproductive System and Pregnancy (4 papers), Cell Adhesion Molecules Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Janet Clarke is often cited by papers focused on Reproductive System and Pregnancy (4 papers), Cell Adhesion Molecules Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Janet Clarke collaborates with scholars based in United States and United Kingdom. Janet Clarke's co-authors include Nancy Wehner, George M. Shopp, Mark X. Sliwkowski, Noël Dybdal, Kathleen McKeever, David E. Allison, Leonard G. Presta, Kelly M. Flagella, Camellia Adams and Neil R. Kitteringham and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Janet Clarke

15 papers receiving 600 citations

Peers

Janet Clarke

ONCOL

RNMI

IMMUN

PHEOH

Daniel Wierda United States

H. Meden Germany

Alissa K. Robbins United States

Laurie Tylaska United States

Artemios B. Vassos United States

M Dimitrijevic Serbia

Clifford Sachs United States

Valerie Relias United States

L‐M Ching New Zealand

Tamer Zeren United States

Daniel Wierda United States

Janet Clarke

112 ×0.4

ONCOL

321 ×1.4

RNMI

470 ×2.1

IMMUN

296 ×1.7

29 ×0.2

PHEOH

Citations per year, relative to Janet Clarke Janet Clarke (= 1×) peers Daniel Wierda

Countries citing papers authored by Janet Clarke

Since Specialization

Citations

This map shows the geographic impact of Janet Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Clarke more than expected).

Fields of papers citing papers by Janet Clarke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Clarke. The network helps show where Janet Clarke may publish in the future.

Co-authorship network of co-authors of Janet Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Clarke. A scholar is included among the top collaborators of Janet Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Clarke. Janet Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hu, Xiao, Kenneth N. Olivier, Mary Crossman, et al.. (2011). In Vivo Pharmacology and Toxicology Evaluation of Polyethylene Glycol-Conjugated Interferon β-1a. Journal of Pharmacology and Experimental Therapeutics. 338(3). 984–996. 24 indexed citations

Wehner, Nancy, George M. Shopp, J. Arly Nelson, et al.. (2009). Immunotoxicity profile of natalizumab. Journal of Immunotoxicology. 6(2). 115–129. 16 indexed citations

Clarke, Janet. (2009). Mechanisms of Adverse Drug Reactions to Biologics. Handbook of experimental pharmacology. 453–474. 33 indexed citations

Wehner, Nancy, George M. Shopp, Satoru Oneda, & Janet Clarke. (2009). Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an α4 integrin inhibitor. Birth Defects Research Part B Developmental and Reproductive Toxicology. 86(2). 117–130. 39 indexed citations

Wehner, Nancy, et al.. (2009). Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an α4 integrin inhibitor. Birth Defects Research Part B Developmental and Reproductive Toxicology. 86(2). 144–156. 43 indexed citations

Wehner, Nancy, et al.. (2009). Effects of natalizumab, an α4 integrin inhibitor, on fertility in male and female guinea pigs. Birth Defects Research Part B Developmental and Reproductive Toxicology. 86(2). 108–116. 23 indexed citations

Wehner, Nancy, George M. Shopp, Meredith S. Rocca, & Janet Clarke. (2009). Effects of natalizumab, an α4 integrin inhibitor, on the development of Hartley guinea pigs. Birth Defects Research Part B Developmental and Reproductive Toxicology. 86(2). 98–107. 30 indexed citations

Clarke, Janet, Christopher Hurst, Pauline L. Martin, et al.. (2007). Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: Is 6 months still appropriate?. Regulatory Toxicology and Pharmacology. 50(1). 2–22. 33 indexed citations

Adams, Camellia, David E. Allison, Kelly M. Flagella, et al.. (2005). Humanization of a recombinant monoclonal antibody to produce a therapeutic HER dimerization inhibitor, pertuzumab. Cancer Immunology Immunotherapy. 55(6). 717–727. 241 indexed citations

10.

Clarke, Janet, Susanne Pippig, Amita Joshi, et al.. (2004). Evaluation of a surrogate antibody for preclinical safety testing of an anti-CD11a monoclonal antibody. Regulatory Toxicology and Pharmacology. 40(3). 219–226. 47 indexed citations

11.

Clarke, Janet, et al.. (1996). Modification of an Enzymatic Glutathione Assay for the Microtiter Plate and the Determination of Glutathione in Rat Primary Cortical Cells. Toxicology Methods. 6(4). 223–230. 4 indexed citations

12.

Hubbard, Andrea K., et al.. (1993). Immunogenicity Studies of A Synthetic Antigen of Alpha Methyl Dopa. Immunopharmacology and Immunotoxicology. 15(5). 621–637. 3 indexed citations

13.

Harrison, Anthony, et al.. (1992). The mechanism of bioactivation and antigen formation of amodiaquine in the rat. Biochemical Pharmacology. 43(7). 1421–1430. 83 indexed citations

14.

Tingle, Malcolm D., et al.. (1990). Influence of Glutathione Conjugation on the Immunogenicity of Dinitrophenyl Derivatives in the Rat. International Archives of Allergy and Immunology. 91(2). 160–165. 8 indexed citations

15.

Silke, Bernard, et al.. (1985). Circulatory effects of intravenous and oral acebutolol in acute myocardial infarction. Clinical Pharmacology & Therapeutics. 38(3). 266–272. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact